SRF
- Market Cap
- ₹74,545 Cr
- P/E
- 32.66
Key Fundamentals
MidcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 14.60%
- Debt to Equity
- 0.35
- EPS (TTM)
- ₹77.01
- Book Value
- ₹516.29
- Market Cap
- ₹74,545 Cr
- P/E (TTM)
- 32.66
- P/B
- 4.87
- ROE
- 14.30%
- Dividend Yield
- 0.20%
- EBITDA
- ₹3,517 Cr
- 52W High
- ₹3,143.00
- 52W Low
- ₹2,178.30
- Day Range
- ₹2,500.50 – ₹2,536.80
- Volume
- 1,42,957
Peer Comparison
Commodities › Chemicals & Petrochemicals › Commodity Chemicals
| 2,514.80 | 32.66 | 74,545 | 4.87 | 0.20% | 14.30% | 14.60% | 18,265 | 2,283 | |
| 1,437.20 | 15.58 | 18,143 | 2.39 | 0.68% | 11.10% | 11.40% | 12,432 | 1,164 | |
| 639.30 | — | 16,287 | 0.74 | 1.73% | 1.27% | 3.42% | 15,420 | −2,175 | |
| 3,375.55 | 100.58 | 7,303 | 9.91 | 0.13% | 20.30% | 23.90% | 784 | 70 | |
| 465.25 | 6.50 | 6,836 | 0.73 | 4.49% | 9.14% | 12.00% | 9,215 | 1,052 | |
| 593.00 | 32.85 | 4,355 | 0.82 | 3.06% | −0.05% | 1.42% | 4,772 | 133 | |
| 445.15 | 8.86 | 4,101 | 1.15 | 2.64% | 13.00% | 17.40% | 3,138 | 473 | |
| Median 7 companies | 639.30 | 24.12 | 7,303 | 1.15 | 1.73% | 11.10% | 12.00% | 9,215 | 473 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 57
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 45
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 78
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 52
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 36
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 44
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
3- Stock is trading at 4.87 times its book value
- Company has a low return on equity of 12.4% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 6 | 5 | 8 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Neutral
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 58.40
- Neutral
- MACD (12,26,9)
- 13.57
- Bullish
- SMA (50)
- 2,461.55
- Bullish
- SMA (200)
- 2,602.24
- Bearish
As of
Analyst Rating
18 of 29 analysts rate Buy, 5 Hold, 6 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +13.14% |
|---|---|
| 5Y | +13.45% |
| 3Y | +2.01% |
| 1Y | +7.45% |
| TTM | +19.67% |
Net profit
| 10Y | +15.62% |
|---|---|
| 5Y | +8.90% |
| 3Y | −5.32% |
| 1Y | +46.68% |
| TTM | +41.19% |
Operating cash flow
| 10Y | +8.89% |
|---|---|
| 5Y | +7.58% |
| 3Y | −4.17% |
| 1Y | +2.69% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +0.63 pp |
|---|---|
| 5Y | −3.79 pp |
| 3Y | −2.13 pp |
| 1Y | +3.10 pp |
| TTM | +1.00 pp |
Revenue by year
| Mar 2017 | ₹4,822 Cr |
|---|---|
| Mar 2018 | ₹5,589 Cr |
| Mar 2019 | ₹7,100 Cr |
| Mar 2020 | ₹7,209 Cr |
| Mar 2021 | ₹8,400 Cr |
| Mar 2022 | ₹12,434 Cr |
| Mar 2023 | ₹14,870 Cr |
| Mar 2024 | ₹13,139 Cr |
| Mar 2025 | ₹14,693 Cr |
| Mar 2026 | ₹15,787 Cr |
Net profit by year
| Mar 2017 | ₹515 Cr |
|---|---|
| Mar 2018 | ₹462 Cr |
| Mar 2019 | ₹642 Cr |
| Mar 2020 | ₹1,019 Cr |
| Mar 2021 | ₹1,198 Cr |
| Mar 2022 | ₹1,889 Cr |
| Mar 2023 | ₹2,162 Cr |
| Mar 2024 | ₹1,336 Cr |
| Mar 2025 | ₹1,251 Cr |
| Mar 2026 | ₹1,835 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
SRF Ltd trades at ₹2,479.4 as of 2026-11-17 with a market cap of ₹73,495.57 crore. The company shows a strong TTM profit growth of 46% and a 10-year sales CAGR of 13%, but its 3-year compounded profit growth stands at -4% and the stock trades at 4.8x book value with a P/E of 32.2x.
- TTM profit growth of 46% signals a sharp earnings recovery after a period of subdued profitability
- 10-year compounded sales growth of 13% demonstrates a consistent long-term revenue expansion track record
- 10-year compounded profit growth of 16% reflects durable earnings power over a full business cycle
- Debt-to-equity ratio of 0.36 as of 2026-11-17 indicates a relatively conservative balance sheet for a capital-intensive chemicals and materials business
- 10-year stock CAGR of 24% shows significant long-term wealth creation for shareholders
- TTM sales growth of 20% indicates accelerating top-line momentum after a 3-year sales CAGR of just 2%
- 10-year average ROE of 17% demonstrates the company's ability to generate healthy returns on shareholder capital over extended periods
- 3-year compounded profit growth of -4% indicates earnings contracted over the medium term before the recent TTM recovery
- P/E of 32.2x as of 2026-11-17 is elevated and prices in significant future growth, leaving limited margin for execution misses
- Price-to-book ratio of 4.8x is high, suggesting the stock commands a steep premium over its net asset value
- 3-year average ROE of 12% is below the 10-year average of 17%, pointing to a sustained decline in capital efficiency during recent years
- Dividend yield of just 0.2% offers negligible income return to shareholders
- 1-year stock return of -12% indicates the market has de-rated the stock over the past year despite the TTM earnings recovery
- 3-year and 5-year stock CAGRs of 2% each suggest the stock has essentially stagnated for half a decade, underperforming broad indices
- Potential capitalisation of interest costs could flatter reported profitability and asset values, masking the true cost of the company's debt-funded capex programmes
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: A quiet period for SRF with no major operational or financial developments. The promoter group entity incrementally raising its stake is a mild positive signal. The GST penalty is negligible relative to SRF's scale and is being contested. With limited news flow, the near-term outlook hinges on broader sector trends and upcoming quarterly results.
- Promoter entity raises stake Nov 11
Kama Realty (Delhi) acquired 1,54,859 SRF shares in the open market, raising its holding to 1.13% (33,54,859 shares). Promoter group buying signals confidence in the company.
- RTA office address change Nov 5
KFin Technologies, SRF's Registrar and Share Transfer Agent, will shift its corporate office address effective December 1, 2026. No operational impact expected.
- Minor GST penalty paid Nov 5
SRF paid ₹12.77 lakh GST penalty under protest in Uttarakhand over a documentation mismatch. The company contests the order, citing a clerical error with tax already discharged.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,177 | 3,053 | 3,570 | 3,464 | 3,424 | 3,491 | 4,313 | 3,819 | 3,640 | 3,713 | 4,615 | 5,033 | 4,904 |
| Expenses | 2,551 | 2,487 | 2,874 | 2,861 | 2,886 | 2,872 | 3,356 | 2,989 | 2,866 | 2,933 | 3,589 | 3,797 | 3,958 |
| Operating Profit | 626 | 566 | 696 | 603 | 538 | 620 | 957 | 830 | 774 | 780 | 1,026 | 1,237 | 946 |
| OPM % | 20% | 19% | 19% | 17% | 16% | 18% | 22% | 22% | 21% | 21% | 22% | 25% | 19% |
| Other Income | 29 | 19 | 23 | 25 | 33 | 40 | 34 | 29 | 26 | −46 | 24.9 | 34 | 25 |
| Interest | 79 | 67 | 90 | 97 | 94 | 96 | 89 | 80 | 71 | 66 | 62 | 69 | 71 |
| Depreciation | 161 | 169 | 186 | 188 | 194 | 194 | 195 | 203 | 212 | 217 | 220 | 223 | 229 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | — | −11.71 | — | — |
| PBT | 415 | 348 | 443 | 344 | 284 | 369 | 707 | 576 | 517 | 452 | 757 | 979 | 671 |
| Tax % | 27% | 27% | 5% | 27% | 29% | 26% | 26% | 25% | 25% | 4% | 23% | 22% | 24% |
| Net Profit | 301 | 253 | 422 | 252 | 201 | 271 | 526 | 432 | 388 | 433 | 582 | 759 | 509 |
| EPS (₹) | 10.15 | 8.55 | 14.24 | 8.51 | 6.79 | 9.14 | 17.75 | 14.58 | 13.10 | 14.60 | 19.63 | 25.60 | 17.18 |
| YoY Sales growth | −15 | −12 | −6 | 4 | 8 | 14 | 21 | 10 | 6 | 6 | 7 | 32 | 35 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,540 | 4,593 | 4,822 | 5,589 | 7,100 | 7,209 | 8,400 | 12,434 | 14,870 | 13,139 | 14,693 | 15,787 | 18,265 |
| Expenses | 3,822 | 3,630 | 3,852 | 4,683 | 5,803 | 5,754 | 6,267 | 9,330 | 11,341 | 10,554 | 11,975 | 12,377 | 14,277 |
| Operating Profit | 717 | 963 | 969 | 906 | 1,297 | 1,455 | 2,133 | 3,103 | 3,529 | 2,584 | 2,718 | 3,410 | 3,988 |
| OPM % | 16% | 21% | 20% | 16% | 18% | 20% | 25% | 25% | 24% | 20% | 18% | 22% | 22% |
| Other Income | 65 | 28 | 73 | 115 | 78 | 152 | 66 | 116 | 75 | 83 | 133 | 107 | 26 |
| Interest | 138 | 130 | 102 | 124 | 198 | 201 | 134 | 116 | 205 | 302 | 376 | 278 | 267 |
| Depreciation | 245 | 275 | 283 | 316 | 358 | 389 | 453 | 517 | 575 | 673 | 772 | 852 | 888 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | — | — | −84.95 | — |
| PBT | 399 | 585 | 657 | 582 | 818 | 1,018 | 1,613 | 2,586 | 2,824 | 1,692 | 1,704 | 2,302 | 2,859 |
| Tax % | 24% | 27% | 22% | 21% | 22% | 0% | 26% | 27% | 23% | 21% | 27% | 20% | — |
| Net Profit | 303 | 430 | 515 | 462 | 642 | 1,019 | 1,198 | 1,889 | 2,162 | 1,336 | 1,251 | 1,835 | 2,283 |
| EPS (₹) | 10.55 | 14.97 | 17.94 | 16.08 | 22.33 | 35.46 | 40.44 | 63.72 | 72.95 | 45.06 | 42.20 | 61.91 | 77.01 |
| Div. Payout % | 19% | 14% | 14% | 15% | 11% | 8% | 12% | 26% | 10% | 16% | 17% | 15% | — |
| Sales growth | 13 | 1 | 5 | 16 | 27 | 2 | 17 | 48 | 20 | −12 | 12 | 7 | 20 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 58 | 58 | 58 | 58 | 58 | 58 | 60 | 297 | 297 | 297 | 297 | 297 | 297 |
| Reserves | 2,238 | 2,705 | 3,124 | 3,506 | 4,071 | 4,875 | 6,796 | 8,268 | 10,030 | 11,182 | 12,329 | 13,745 | 15,007 |
| Borrowings | 2,435 | 2,515 | 2,396 | 3,142 | 3,730 | 4,135 | 3,469 | 3,655 | 4,478 | 5,031 | 4,726 | 5,083 | 5,375 |
| Other Liabilities | 1,152 | 1,146 | 1,389 | 1,657 | 2,028 | 1,795 | 2,586 | 3,544 | 3,931 | 3,945 | 4,169 | 4,971 | 5,157 |
| Total Liabilities | 5,883 | 6,424 | 6,968 | 8,363 | 9,888 | 10,862 | 12,911 | 15,765 | 18,736 | 20,454 | 21,521 | 24,097 | 25,837 |
| Fixed Assets | 3,922 | 4,113 | 4,405 | 5,122 | 5,609 | 6,368 | 7,827 | 8,425 | 10,050 | 13,242 | 13,720 | 13,926 | 14,543 |
| CWIP | 104 | 117 | 259 | 559 | 754 | 1,393 | 772 | 1,672 | 2,406 | 805 | 811 | 1,889 | 2,122 |
| Investments | 94 | 165 | 196 | 122 | 101 | 203 | 417 | 321 | 494 | 527 | 827 | 687 | 601 |
| Other Assets | 1,762 | 2,029 | 2,109 | 2,561 | 3,424 | 2,899 | 3,895 | 5,347 | 5,786 | 5,881 | 6,163 | 7,594 | 8,571 |
| Total Assets | 5,883 | 6,424 | 6,968 | 8,363 | 9,888 | 10,862 | 12,911 | 15,765 | 18,736 | 20,454 | 21,521 | 24,097 | 25,837 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 542 | 1,090 | 645 | 678 | 896 | 1,304 | 1,772 | 2,106 | 2,902 | 2,094 | 2,487 | 2,554 |
| Investing | −500 | −667 | −613 | −1,174 | −1,039 | −1,179 | −1,499 | −1,586 | −2,964 | −2,231 | −1,482 | −1,589 |
| Financing | −18 | −182 | −284 | 495 | 246 | −199 | −251 | −207 | 220 | −72 | −1,071 | −708 |
| Net Cash Flow | 24 | 241 | −252 | −1 | 103 | −73 | 22 | 312 | 158 | −209 | −65 | 256 |
| Free Cash Flow | 58 | 511 | 5 | −605 | −157 | −69 | 567 | 289 | 50 | −108 | 1,265 | 747 |
| CFO/EBITDA | 87 | 125 | 79 | 88 | 81 | 99 | 95 | 81 | 97 | 96 | 104 | 90 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 41 | 50 | 44 | 53 | 45 | 55 | 53 | 44 | 54 | 54 | 59 |
| Inventory Days | 110 | 105 | 126 | 115 | 113 | 119 | 133 | 129 | 112 | 127 | 111 | 131 |
| Days Payable | 83 | 112 | 122 | 126 | 127 | 110 | 144 | 126 | 110 | 120 | 111 | 121 |
| Cash Conversion Cycle | 75 | 34 | 54 | 34 | 38 | 54 | 45 | 55 | 46 | 61 | 55 | 69 |
| Working Capital Days | 10 | 1 | −15 | −21 | −17 | −37 | −14 | 1 | −6 | −18 | −9 | −12 |
| ROCE % | 11% | 14% | 14% | 11% | 14% | 14% | 18% | 24% | 22% | 13% | 12% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view SRF insights
63 extracted metrics across FY11–FY27.
Documents
- Concall · Oct 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 28 Sep 2026
- 10 Jun 2026
- 21 May 2026
- 11 Jun 2025
- 21 May 2025
Frequently Asked Questions about SRF
What does SRF Ltd do?
Where is SRF Ltd (SRF) listed?
Which sector does SRF Ltd belong to?
What is the market capitalisation of SRF Ltd?
What is the PE ratio of SRF Ltd?
What is the 52-week high and low of SRF Ltd?
Does SRF Ltd pay dividends?
What is the Return on Equity (ROE) of SRF Ltd?
Company Information
Incorporated in 1970, SRF Ltd manufactures and sells technical textiles, chemicals, packaging films, aluminum foils, and other polymers
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SRF.md for SRF Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.